Healius (ASX:HLS) Common Stock: A$2,604 Mil (As of Dec. 2025)


ASX:HLS Healius Ltd ASX:HLS
49 GF Score
Price A$0.37
GF Value A$1.01
Valuation Possible Value Trap
! 7 Warning Signs
View Full Analysis

What is Healius Common Stock?

Healius ASX:HLS +1.39% 49 Common Stock is A$2,604 Mil as of Dec. 2025. GuruFocus rates ASX:HLS with a GF Score™ of 49/100 and a GF Value™ of A$1.01 (Possible Value Trap). The stock has 7 warning signs investors should review.

Healius's quarterly common stock stayed the same from Dec. 2024 (A$2,604 Mil) to Jun. 2025 (A$2,604 Mil) and stayed the same from Jun. 2025 (A$2,604 Mil) to Dec. 2025 (A$2,604 Mil).

Healius's annual common stock increased from Jun. 2023 (A$2,421 Mil) to Jun. 2024 (A$2,604 Mil) and increased from Jun. 2024 (A$2,604 Mil) to Jun. 2025 (A$2,604 Mil).

Healius Common Stock Historical Data

* Premium members only.

The historical data trend for Healius's Common Stock can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Healius Common Stock Chart

Healius Annual Data
Trend Jun16 Jun17 Jun18 Jun19 Jun20 Jun21 Jun22 Jun23 Jun24 Jun25
Common Stock
Get a 7-Day Free Trial Premium Member Only Premium Member Only 2,572.00 2,422.90 2,421.00 2,603.90 2,604.00

Healius Semi-Annual Data
Jun16 Dec16 Jun17 Dec17 Jun18 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23 Jun24 Dec24 Jun25 Dec25
Common Stock Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 2,603.90 2,603.90 2,604.00 2,604.00 2,604.00
ASX:HLS
49GF Score
Healius Ltd ASX:HLS
Common Stock is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Healius Common Stock Calculation

Common stock is listed on the Balance Sheet at the par value of the total shares outstanding of a company.

The par value of common stocks is meaningless. It is usually set at an absurdly low number.

Frequently Asked Questions Learn more about Common Stock →
What does a Common Stock of A$2,604 Mil mean?
Healius (ASX:HLS) has a Common Stock of A$2,604 Mil as of Dec. 2025. Common Stock is the par value of a company's shares outstanding, as listed on the balance sheet. View historical data on Healius and its competitors.
Is Healius' Common Stock too high?
Healius' current Common Stock is A$2,604 Mil. Overall, Healius has a GF Score™ of 49/100 and is considered Possible Value Trap, reflecting its overall financial health beyond just this single metric.
How does Healius' Common Stock compare to TMO and DHR?
Healius' Common Stock of A$2,604 Mil can be compared against companies in the Medical Diagnostics & Research industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Common Stock for a Medical Diagnostics & Research company?
A good Common Stock depends on the Medical Diagnostics & Research industry context. However, Common Stock should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Common Stock mean?
A high Common Stock can signal that a stock is expensive relative to its fundamentals. Common Stock is the par value of a company's shares outstanding, as listed on the balance sheet. View historical data on Healius and its competitors. Healius's current Common Stock is A$2,604 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Healius stock overvalued right now?
Based on GuruFocus' analysis, Healius (ASX:HLS) is currently considered Possible Value Trap. The stock's GF Value™ is A$1.01, compared to a current price of A$0.37 — trading 63.9% below its estimated fair value. The current Common Stock is A$2,604 Mil. Healius' overall GF Score™ is 49/100 with 7 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Common Stock calculated?
Common Stock is calculated from a company's financial statements. For Healius (ASX:HLS), the current Common Stock is A$2,604 Mil as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Healius (ASX:HLS) Overvalued in 2026?

Based on GuruFocus' analysis, Healius stock appears to be undervalued. The current stock price of A$0.37 is trading 63.9% below its estimated GF Value™ of A$1.01. GuruFocus considers Healius to be Possible Value Trap.

Key valuation signals for ASX:HLS:

  • Common Stock: A$2,604 Mil
  • GF Value™: A$1.01 vs. price of A$0.37 (63.9% below fair value)
  • GF Score™: 49/100 with 7 warning signs

No single metric tells the full story. See the ASX:HLS stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Healius Business Description

Other Exchanges PGZ:Germany
Address 161 Castlereagh Street, Level 22, Sydney, NSW, AUS, 2000
Healius is Australia's second-largest pathology provider. Pathology revenue is almost entirely earned via the public health Medicare system and makes up the majority of Healius' group revenue. A small portion comes from its clinical testing business, Agilex.
49GF Score

Get the complete analysis for ASX:HLS

Common Stock is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

A$0.37
Price
A$1.01
GF Value